LUCA Science is at the forefront of a new kind of mitochondrial therapy that aims to restore cellular bioenergetics in malfunctioning or damaged tissues and organs. Using our patented iMIT technology, LUCA Science is creating a novel platform of highly functional mitochondria. We could boost bioenergetics and restore normal activities by supplyingintact and functional mitochondria to the affected tissues. The utilization of mitochondria as a biopharmaceutical agent would be groundbreaking for treating a wide range of unmet medical needs.

Biotechnology

Health Care

Pharmaceutical

LUCA Science Inc.

LUCA Science Inc.'s headquarters in Tokyo, Japan

Rick C. Tsai

Yosuke Matsumiya

Hisashi Ohta

Tomoyuki Inoue

Yoshikazu Tokuoka

Masashi Suganuma

Leadership Team

Research and Development

LUCA Science Inc.

Org chart

Teams

Leadership Team

Research and Development

Offices

Similar companies